Polar Asset Management Partners’s Terns Pharmaceuticals TERN Stock Holding History

Polar Asset Management Partners’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-725,000	Closed	-$38.2M	–	958
2026 Q1	$38.2M	Buy	+725,000	New	+$29.8M	0.76%	24
2023 Q4	–	Sell	-100,000	Closed	-$503K	–	902
2023 Q3	$503K	Hold	100,000	–	–	0.01%	498
2023 Q2	$875K	Hold	100,000	–	–	0.02%	529
2023 Q1	$1.18M	Hold	100,000	–	–	0.02%	560
2022 Q4	$1.02M	Buy	+100,000	New	+$666K	0.01%	689

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Polar Asset Management Partners's TERN Position: Q2 2026 in Review

Polar Asset Management Partners sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 725,000 shares — an estimated $38.2M sold.

Polar Asset Management Partners first reported a position in TERN in Q4 2022 and held it in 5 quarters. The position peaked at $38.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Polar Asset Management Partners reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Polar Asset Management Partners sold 725,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $38.2M.
Polar Asset Management Partners first reported a position in Terns Pharmaceuticals in Q4 2022 and held it in 5 quarters.
Polar Asset Management Partners's Terns Pharmaceuticals position peaked at $38.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Polar Asset Management Partners's 13F filing for Q2 2026, filed 14 Aug 2026.